Ultrasound imaging used to identify fetal sex without a medical indication is becoming a public health issue and should be discouraged.
Ultrasounds should not be used solely to identify fetal sex unless there is a medical indication for the scan, according to a joint statement issued by the Society of Obstetricians and Gynaecologists of Canada and the Canadian Association of Radiologists, published in the Journal of Obstetrics and Gynaecology Canada.
The easy availability of ultrasound and its perceived safety by the public has led to an increase in “entertainment” ultrasounds performed by non-medical clinics to determine fetal sex during the first trimester of pregnancy and to offer “keepsake” photos.
However, the staff at such clinics may not have the training, expertise, nor medical backgrounds required to safely perform such examinations. In addition, the operators may not have the expertise to identify potential problems for both mother and child, possibly resulting in a false sense of security, and there is the risk of false-positive diagnosis, which adds to anxiety and possible extra unnecessary testing.
While no danger has yet been absolutely determined regarding the use of ultrasounds during pregnancy, there is a theoretical risk to the fetus.
“Of particular concern are recent studies in animal models that report subtle effects on the physiology and development of the fetal brain,” the authors wrote.
Health Canada does not recommend that ultrasounds be used in this fashion and the FDA views entertainment or “keepsake” ultrasounds as unapproved use of a medical device.
“The FDA cautions that those who subject individuals to ultrasound exposure using a diagnostic ultrasound device (a prescription device) without a physician’s order may be in violation of state or local laws or regulations regarding use of a prescription medical device,” the organizations noted.
The two associations are calling on governments to join with them and find a solution to this public health issue.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.